Saturday, February 25, 2006


Q. i was wondering what you have to say about a 50 y/o male with a viral load never above 400, but cd4 ranges of 100-200 over the last 5 years.

A. Rare, but described. It used to be referred to as "slow, low", meaning people who are infected and took a big hit early with their CD4 count, but then are stable at low counts with low viral (primarily) or undetectable viral loads. It was thought that their virus replicated at a much slower rate.
--Dr. Holodniy

so i'm a rare breed eh.

Wednesday, February 22, 2006

San Francisco - Folsom Street

Saturday, February 18, 2006

August 1979

i remember this because of hurricane david, being in fort lauderdale at the time. and of course, being a hurricane of the same name i have made it more memorable than usual. but i can say i was in fort lauderdale in 1979 during that year. where i went after that i'm not sure. i'll have to meditate on it a while longer.

Wednesday, February 08, 2006

itunes is choking

i'm trying to put 3600 tunes into itunes. it's choking. bad.

could this be real??

Researchers, including a BYU scientist, believe they have found a new compound that could finally kill the HIV/AIDS virus, not just slow it down as current treatments do.

And, unlike the expensive, drug cocktails 25 years of research have produced for those with the deadly virus, the compound invented by Paul D. Savage of Brigham Young University appears to hunt down and kill HIV.

Although so far limited to early test tube studies, CSA-54, one of a family of compounds called Ceragenins (or CSAs), mimics the disease-fighting characteristics of anti-microbial and anti-viral agents produced naturally by a healthy human immune system.

Under a study sponsored by Ceragenix Pharmaceuticals, Savage and his colleagues developed and synthesized the compound for Vanderbilt University's School of Medicine. In his Nashville, Tenn., laboratories, Derya Unutmaz, an associate professor of Microbiology and Immunology, tested several CSAs for their ability to kill HIV.

While issuing a cautious caveat about his early results, Unutmaz acknowledged Monday that CSAs could be the breakthrough HIV/AIDS researchers have sought for so long.